Medical Marijuana, Inc. Subsidiary Phyto Animal Health Announces Expert Veterinary Advisory Board

Leading Producer of Hemp-Based CBD for Companion Animals Announces Team of World-Class Industry Experts
SAN DIEGO, Feb. 8, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary Phyto Animal Health announced today the establishment of its Veterinary Advisory Board.
Phyto Animal Health’sAdvisory Board is comprised of recognized experts in veterinary medicine and animal sciences. The Board’s mandate is to create animal-safe products and build upon the Company’s industry-leading standards to continue to ensure substantive, in-depth, science-based standards of practice.
The Phyto Animal Health Veterinary Advisory Board was created after several months of rigorous research, outreach and coordination with leaders in the private, public, academic and veterinary sectors. The Company also consulted with the Veterinary Cannabis Academy for additional guidance on research, advocacy and education about hemp for veterinary medicine. The Board members’ expertise spans fields relevant to ensuring the physical, emotional and long-term health of companion animals.
“This team of well-respected experts will continue to help Phyto Animal Health become a leader in the animal health and wellness market,” said Phyto Animal Health CEO Ian Quinn. “They can provide us with the knowledge needed to create safe, effective products that can help us provide our pets with happier, healthier lives.”
“We take pride in the fact that all of the products created by our portfolio of companies are stringently tested and created by industry experts,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “This Advisory Board is our latest example of that and we are excited to see how they can help us continue to improve the quality and education of the unique offerings of Phyto Animal Health.”
Phyto Animal Health is honored to welcome its first members, in alphabetical order:
Stephen Cital, RVT, SRA, RLAT, VTS-Lab Animal is the Executive Director for the Academy of Laboratory Animal Veterinary Technicians and Nurses and Training Manager and Surgery Service Lead at Silicon Valley Veterinary Specialists in San Jose, CA. He is also the Vice President and current liaison for the California RVT Association and member at large for the National Association of Veterinary Technicians in America.
Liz Hughston, MEd., RVT, CVT, VTS (SAIM, ECC) is the President-Elect of the Academy of Internal Medicine Veterinary Technicians. She has been practicing as a veterinary technician in California for more than a decade and is an adjunct professor at the Penn Foster College Veterinary Technology Program. She is a frequent and sought-after national and international speaker on topics such as critical care, emergency, small animal internal medicine and professional development. In 2013, she received CaRVTA’s inaugural RVT of the Year Award.
William Muir III, DVM, Ph.D., DACVAA, DACVECC, nicknamed the “Godfather of Anesthesia and Pain Management in Veterinary Medicine,” has served as Chief Medical Officer for The Animal Medical Center of New York and was a Professor of the Department of Veterinary Clinical Sciences at The Ohio State University for 37 years. He is board certified in veterinary anesthesia and veterinary medicine and critical care, a fellow of the American Academy of Clinical Pharmacology, regional director of the International Veterinary Academy of Pain Management and a member of the American Veterinary Medical Association. He earned his bachelor’s and veterinary degrees (DVM) from Michigan State University and his MS and Ph.D. from The Ohio State University.
Robert J. Klostermann, DVM, has practiced veterinary medicine for 60 years and established the Middleton Veterinary Hospital in 1978. He graduated from Iowa State University, College of Veterinary Medicine that same year. His interests lie in internal medicine, surgery and dentistry with specialty in production of animal medicine and diagnostics. He has also served as President of the Wisconsin Veterinary Medical Association.
About Phyto Animal Health
As a company that cares about the health and wellbeing of all animals, Phyto Animal Health also cares about the earth. Using the least amount of water and other resources to create its products, the Company aims to leave the smallest footprint possible while helping provide cats, dogs and horses with the nutrients they need to have outstanding mental and physical health.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Andrew Hard
Chief Executive Officer CMW Media
P. 858-264-6600
The post Medical Marijuana, Inc. Subsidiary Phyto Animal Health Announces Expert Veterinary Advisory Board appeared first on Medical Marijuana, Inc..

Go to Source

Powered by WPeMatico